Evidence map›Paper›PMID 38414413›Full record

ArticleNanoscale2024

Graphene oxide activates canonical TGFβ signalling in a human chondrocyte cell line

Leona Ogene, Steven Woods, Joseph Hetmanski, Neus Lozano, Angeliki Karakasidi, Patrick T Caswell, Kostas Kostarelos, Marco A N Domingos, Sandra Vranic, Susan J Kimber

Open access · hybridAbstract read
In one paragraph

Article in Nanoscale, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Leona OgeneDivision of Cell Matrix Biology & Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PT, UK. sue.kimber@manchester.ac.uk.ORCID http://orcid.org/0000-0003-2041-4377
Steven WoodsDivision of Cell Matrix Biology & Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PT, UK. sue.kimber@manchester.ac.uk.
Joseph HetmanskiWellcome Trust Centre for Cell-Matrix Research, University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PT, UK.ORCID http://orcid.org/0000-0002-1493-351X
Neus LozanoNanomedicine Lab, Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB Bellaterra, 08193 Barcelona, Spain.ORCID http://orcid.org/0000-0002-9026-1743
Angeliki KarakasidiNano-Cell Biology Lab, Division of Cell Matrix Biology & Regenerative Medicine, School of Biological Sciences, The University of Manchester, Manchester, M13 9PT, UK.
Patrick T CaswellWellcome Trust Centre for Cell-Matrix Research, University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PT, UK.
Kostas KostarelosNanomedicine Lab, Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB Bellaterra, 08193 Barcelona, Spain.ORCID http://orcid.org/0000-0002-2224-6672
Marco A N DomingosDepartment of Solids and Structure, School of Engineering, Faculty of Science and Engineering, Henry Royce Institute, The University of Manchester, Manchester, UK.ORCID http://orcid.org/0000-0002-6693-790X
Sandra VranicNano-Cell Biology Lab, Division of Cell Matrix Biology & Regenerative Medicine, School of Biological Sciences, The University of Manchester, Manchester, M13 9PT, UK.ORCID http://orcid.org/0000-0002-6653-7156
Susan J KimberDivision of Cell Matrix Biology & Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PT, UK. sue.kimber@manchester.ac.uk.
University of Manchester · GBManchester Academic Health Science Centre · GBInstitució Catalana de Recerca i Estudis Avançats · ESInstitut Català de Nanociència i Nanotecnologia · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Graphene Oxide (GO) has been shown to increase the expression of key cartilage genes and matrix components within 3D scaffolds. Understanding the mechanisms behind the chondroinductive ability of GO is critical for developing articular cartilage regeneration therapies but remains poorly understood. The objectives of this work were to elucidate the effects of GO on the key chondrogenic signalling pathway - TGFβ and identify the mechanism through which signal activation is achieved in human chondrocytes. Activation of canonical signalling was validated through GO-induced SMAD-2 phosphorylation and upregulation of known TGFβ response genes, while the use of a TGFβ signalling reporter assay allowed us to identify the onset of GO-induced signal activation which has not been previously reported. Importantly, we investigate the cell-material interactions and molecular mechanisms behind these effects, establishing a novel link between GO, the plasma membrane and intracellular signalling. By leveraging fluorescent lifetime imaging (FLIM) and a membrane tension probe, we reveal GO-mediated increases in plasma membrane tension, in real-time for the first time. Furthermore, we report the activation of mechanosensory pathways which are known to be regulated by changes in plasma membrane tension and reveal the activation of endogenous latent TGFβ in the presence of GO, providing a mechanism for signal activation. The data presented here are critical to understanding the chondroinductive properties of GO and are important for the implementation of GO in regenerative medicine.

Indexed as

Cartilage, ArticularChondrocytesGraphiteCell LineCell MembraneHumansTransforming Growth Factor betagraphene oxideGraphiteTransforming Growth Factor beta

Identifiers

PMID38414413
PMCPMC10939054
OpenAlexW4391944329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.